Drug reaction with eosinophilia and systemic symptoms
ORPHA:139402DiseaseNot applicableAll ages
Фенотипы (HPO)28
Очень частый (80–99%)12
HP:0000988Skin rash
HP:0001019Erythroderma
HP:0001695Cardiac arrest
HP:0001824Weight loss
HP:0001945Fever
HP:0002383Infectious encephalitis
HP:0002716Lymphadenopathy
HP:0010783Erythema
HP:0012733Macule
HP:0100326Immunologic hypersensitivity
HP:0100646Thyroiditis
HP:0100665Angioedema
Частый (30–79%)4
HP:0002113Pulmonary infiltrates
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0006515Interstitial pneumonitis
HP:0100827Lymphocytosis
Периодический (5–29%)12
HP:0000083Renal insufficiency
HP:0000100Nephrotic syndrome
HP:0001880Eosinophilia
HP:0001970Tubulointerstitial nephritis
HP:0002094Dyspnea
HP:0006554Acute hepatic failure
HP:0009830Peripheral neuropathy
HP:0012115Hepatitis
HP:0012735Cough
HP:0012819Myocarditis
HP:0030249Enanthema
HP:0200039Pustule
Эпидемиология1
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)